Perrigo Company plc (PRGO) Form 8-K Summary (11/05/2025)

Perrigo announced the release of Q3 2025 earnings (Exhibit 99.1).

The most material update is the initiation of a strategic review of its infant formula business (Item 7.01).

Key Investor Notes:

• Management strongly relies on non-GAAP financial measures for performance evaluation, adjusting for items like amortization, litigation, and restructuring charges. Investors must review GAAP reconciliation.
• The filing lists several outstanding debt instruments, including notes due in 2030, 2032, 2043, and 2044, all regist